 Ayala Pharmaceuticals, Inc NASDAQ:AYLA Investment analysts at Oppenheimer decreased their Q2 2020 earnings estimates for Ayala Pharmaceuticals in a report issued on Monday, June 22nd. Oppenheimer analyst J. Olson now forecasts that the company will post earnings of 0.60 per share for the quarter, down from their previous estimate of 0.54. Oppenheimer has a ... 